Feasibility of Nano-Hydroxyapatite/chitosan/calcium Sulphate Hemihydrate As an Injectable Bone Tissue Engineering Scaffold
Xue Zhen,Niu Li-yuan,An Gang,Guo Ya-shan,Lv Song-cen
DOI: https://doi.org/10.3969/j.issn.2095-4344
2015-01-01
Abstract:BACKGROUND:In preliminary experiments, injectable nano-hydroxyapatite/chitosan/calcium sulphate hemihydrates (nHA/CS/CSH) composites have been developed based on the bionics principle, but the biocompatibility of this composite with bone marrow mesenchymal stem cels is not very clear. OBJECTIVE:To study the feasibility of nHA/CS/CSH as an injectable bone tissue engineering scaffold. METHODS: Bone marrow mesenchymal stem cels from rabbits were cultured and induced, and the third passage cels were cultured with nHA/CS/CSH as an experimental group. Bone marrow mesenchymal stem cels subjected to inoculated culture were used as controls. The morphology and growth of the cels were observed under inverted phase contrast microscope. MTT assay was used to examine cel proliferation. The morphology and proliferation of the cels on the surface of nHA/CS/CSH was observed by scanning electron microscope. The nHA/CS/CSH scaffold was implanted into the rabbit sacrospinal muscles, and pathologicaly observed after 2, 4, 6, 8 weeks. RESULTS AND CONCLUSION:Bone marrow mesenchymal stem cels co-cultured with nHA/CS/CSH exhibited good growth as observed under inverted phase contrast microscope, without significant difference from those in the control group. At 2 weeks after scaffold implantation, a moderate amount of neutrophils, lymphocytes and giant cels infiltrated around the graft material, smal blood vessels and fibroblasts proliferated, and the graft material was divided and embraced by inflammatory cels; at 4 weeks after implantation, a few lymphocytes, fibroblasts aggregated, the inflammation subsided further, and muscle fibers showed normal arrangement and morphology; at 6 weeks after implantation, the inflammation around the graft material became mild and tissue edema was not obvious; at 8 weeks after implantation, the inflammation subsided basicaly, the material degradation was complete, and the muscle fibers had normal morphology. These findings indicate that the nHA/CS/CSH composite material has good biocompatibility and biodegradation, which may be used as a good scaffold material for injectable bone tissue engineering scaffold.